ABSTRACT: Synovial joints and articular cartilage play crucial roles in the skeletal function, but relatively little is actually known about their embryonic development. Here we first focused on the interzone, a thin mesenchymal cell layer forming at future joint sites that is widely thought to be critical for joint and articular cartilage development. To determine interzone cell origin and fate, we microinjected the vital fluorescent dye DiI at several peri-joint sites in chick limbs and monitored the behavior and fate of labeled cells over time. Peri-joint mesenchymal cells located immediately adjacent to incipient joints migrated, became part of the interzone, and were eventually found in epiphyseal articular layer and joint capsule. Interzone cells isolated and reared in vitro expressed typical phenotypic markers, including GDF-5, Wnt-14, and CD-44, and differentiated into chondrocytes over time. To determine the molecular mechanisms of articular chondrocyte formation, we carried out additional studies on the ets transcription factor family member ERG and its alternatively spliced variant C-1-1 that we previously found to be expressed in developing avian articular chondrocytes. We cloned the human counterpart of avian C-1-1 (ERGp55Δ81) and conditionally expressed it in transgenic mice under cartilage-specific Col2 gene promotor-enhancer control. The entire transgenic mouse limb chondrocyte population exhibited an immature articular-like phenotype and a virtual lack of growth plate formation and chondrocyte maturation compared to wild-type littermate. Together, our studies reveal that peri-joint mesenchymal cells take part in interzone and articular layer formation, interzone cells can differentiate into chondrocytes, and acquisition of a permanent articular chondrocyte phenotype is aided and perhaps dictated by ets transcription factor ERG.
INTRODUCTION
Synovial joints are crucial for skeletal function and quality of life. As a result, joint biology remains the subject of extensive research activity and much is known about structure and composition of articular cartilage, ligaments, synovium, and joint capsule and the specific roles each of these tissues plays in joint function in growing and adult organisms. 1 Much is also known about the susceptibility of joint tissues to damage and malfunction during natural aging and congenital or acquired skeletal conditions. Natural aging is characterized by a progressive loss of extracellular matrix and resilience in articular cartilage, resulting in stiffness and reduced biomechanical properties. Osteoarthritis and rheumatoid arthritis are common conditions that affect billions of patients worldwide. These pathologies target and disrupt structure and function in articular cartilage, synovium, or meniscus and result in painful, debilitating, and costly conditions for patients and society.
In comparison, there continues to be only limited information on the processes and mechanisms by which synovial joints actually form during embryogenesis and become established in fetal and early postnatal life. [2] [3] [4] Classic studies showed several years ago that the blueprint of the developing skeleton in early embryonic limbs consists at first of an interrupted condensed mesenchymal structure (FIG. 1A) . [5] [6] [7] The first oversign of joint formation is the appearance of an interzone at each future joint site, be it a phalangeal, carpal, tarsal, or elbow site (FIG. 1B) . The interzone is made of mesenchymal cells that are in close proximity to each other and connected by gap junctions. 3 The adjacent condensed mesenchymal cells differentiate into chondrocytes and produce the cartilaginous framework of the skeleton (FIG. 1B) . With time, the interzone thickens (FIG. 1C) , and the interzone cells are thought to give rise to chondrocytes that are apposed at each epiphyseal end and participate in initial longitudinal lengthening of the long bone anlagen. The cells are also thought to take part in morphogenetic processes that begin to mold the opposing interlocking sides of each joint (FIG. 1D) and to eventually give rise to articular chondrocytes and other components including ligaments (FIG. 1E) .
Clearly, joint formation is a complex multistep process, but details about the process remain rather scanty. It would be highly desirable to know precisely how each step is regulated, how the joint formation sites are initially determined and committed, how interzone cells form and whether they indeed give rise to articular chondrocytes and/or other joint tissues, and how each joint acquires its characteristic three-dimensional configuration and structure, be it an elbow or a hip. This information would be of obvious biological interest and would FIGURE 1. Schematic representation of the major steps of synovial joint formation. Mesenchymal pre-chondrogenic condensations appearing in the early limb bud exhibit no oversigns of joint formation and are thus uninterrupted (A). Unknown upstream mechanisms possibly involving Hox genes determine the exact location for joint initiation, and the first overt morphological sign of joint formation is a further gathering and condensation of cells (B). Soon after, the interzone becomes readily recognizable as a thicker and quite compact structure oriented perpendicularly to long axis of the long bone anlagen and composed of mesenchymal cells connected by gap junctions (C). The interzone and its adjacent epiphyseal cartilaginous tissue initiate a morphogenetic process that will eventually mold the joint into its required and distinct three-dimensional configuration (D). Eventually, all the distinct components of a mature joint form and include articular cartilage and capsule (E). also have major biomedical relevance, value, and implications. The present study was conducted to address some of these questions and issues.
INTERZONE CELLS

Origin and Differentiation Potential
Given that an interzone forms at each future joint site, one could assume that its cells are merely part of the initial uninterrupted mesenchymal condensations; that is, interzone cells would simply be those cells that chance to occupy each future joint site. An alternative possibility is that interzone cells are a distinct population of cells that originate in peri-joint sites and migrate into the nascent joint. To test these possibilities, we made use of a popular approach consisting of microinjection of the fluorescent vital dye DiI that allows monitoring of behavior and fate of labeled cells over developmental time. For instance, this approach has been used to identify and characterize the multiple sites from which progenitor cells originate and give rise to the heart and its distinct portions in the early chick embryo. 8 Accordingly, we microinjected DiI at sites close to incipient joints in the leg buds of day 6.5 chick embryos in ovo (one site per leg bud), and eggs were re-incubated and analyzed over time. At each time point parasagittal sections of the limbs (i.e., along the dorsal-ventral axis) were prepared and processed for fluorescence microscopy. DiI-labeled cells had apparently migrated from the site of DiI microinjection (FIG. 2A , arrow) and were present all along the developing epiphyseal joint and interzone by 2 days after injection (FIG. 2A, arrowheads) . When we examined companion specimens on day 3 from injection, we found that labeled cells occupied the articulating layer of the long bone anlagen (not shown). To assess specificity, we microinjected DiI at sites what were 0.2-0.7 mm further away from incipient joints in companion embryos (FIG. 2B, arrow) . Interestingly, the labeled cells appeared to have migrated in these embryos as well, but had done so up and down the limb mesenchyme and not into the nascent joint (FIG. 2B) .
Understanding of interzone cell biology would be greatly aided if the cells could be isolated and studied in tissue culture directly, a rather difficult task given the interzone's small size and cell number. Using our expertise with embryonic tissue microdissection and micromanipulation, we set out to develop methods for interzone isolation and cell culturing. To monitor the dissection process, we first microinjected DiI into the interzones of day 7.5 chick embryo or E14.5 mouse embryo autopods. At these stages, the metatarsal-phalangeal and inter-phalangeal interzones are visible under a dissecting scope by virtue of their differential optical characteristics and are readily distinguishable from adjacent cartilaginous tissue. DiI-labeled interzones were then dissected off the adjacent cartilage. Interzones were trypsinized into single cell suspensions, and cells were plated in monolayer in medium 199 containing fetal bovine serum. During the first 2 days of culture, the cells exhibited a fibroblastic morphology and proliferated actively (FIG. 3A) and expressed a number of characteristic marker genes, including Wnt-14, GDF-5, Gli-3, CD-44, and collagen IIA as revealed by RT-PCR (FIG. 3C , lanes 1-5, respectively). By day 7 of culture, many of the cells had acquired a round architecture and a highly refractile contour typical of chondrocytes in culture (FIG. 3B) and now expressed high levels of markers of the chondrocyte phenotype including collagen IX and aggrecan (FIG. 3D, lanes 2 and 4) compared to the much lower levels expressed on day 2 (FIG. 3D, lanes 1 and 3) .
ARTICULAR CARTILAGE DEVELOPMENT
Ets Transcription Factors
The cell fate maps shown above suggest that interzone cells give rise to the articular layer of long bone anlagen. The data imply that articular chondrocytes have a distinct embryonic origin as compared to the chondrocytes that derive from the mesenchymal condensations and form the bulk of the anlagen (heretofore called transient chondrocytes) ( see FIG. 1 ). There are other substantial differences between articular chondrocytes and transient chondrocytes. Articular chondrocytes maintain joint function throughout life and do so by retaining a stable and permanent phenotype, producing all the macromolecular components of articular cartilage including aggrecan and collagen II, and providing the tissue with functional resilience. Instead, transient chondrocytes display a very dynamic phenotype, undergo proliferation, maturation, hypertrophy, and apoptosis in the growth plates, and are eventually replaced by bone cells during endochondral ossification. Interestingly, even articular chondrocytes can potentially undergo maturation and hypertrophy and display traits of transient growth plate chondrocytes. Such a shift from a permanent to a transient chondrocyte phenotype is often seen in the joints of osteoarthritic patients and can even be provoked in healthy adult articular chondrocytes once isolated from the joint and reared in monolayer culture. 9, 10 Traits expressed by such abnormal articular chondrocytes include an enlarged hypertrophic cell size, metalloproteases, and alkaline phosphatase, traits that are incompatible with joint function and lead/cause joint disease. What the above studies and findings imply is that articular chondrocytes must actively safeguard their permanent stable phenotype with strong mechanisms to exert function throughout life and to prevent maturation and hypertrophy and hence loss of cell and tissue function. In other words, as soon as articular chondrocytes form at the epiphyseal ends of long bone anlagen (presumably as the descendants of interzone cells), the cells must acquire mechanisms to establish and retain a permanent phenotype.
In searching for such mechanisms, we previously focused on the transcription factor ERG. This factor belongs to the ets family of transcription factors.
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The current 26 family members are involved in a variety of cellular and developmental processes and when mutated or misexpressed, can cause pathologies. [11] [12] [13] Ets proteins share a highly conserved 85-amino acid domain (the ETS domain) that binds to the consensus DNA core sequence 5 -GGA(A/T)-3 .
14 Individual ets proteins can select specific nucleotides over an 11-bp sequence centered around the core sequence. Additional specificity is provided by interactions with other transcription factors, including members of the bHLH, Pax, bZIP, Id, and nuclear hormone receptor families. 15, 16 The biological function of ets proteins is also modulated by phosphorylation and by conformational changes consequent to interactions with other factors. 11, 17, 18 Structural studies have revealed that the ETS domain is a variant of the winged helix-turn-helix motif and displays three ␣-helices and four ␤-sheets, with the main protein-DNA contacts provided by residues located along the third ␣-helix. Though the ETS domain is highly conserved with the family, ets proteins differ from each other in other domains (such as absence or presence of the pointed/SAM domain) and are thus distinguished in subfamilies.
11,16
ERG and Articular Cartilage Development
The ets member ERG has been widely studied for its involvement in human cancers following gene translocation to form fusion proteins. 19 ERG is also linked to normal processes, such as mesoderm formation and has been found to form functional complexes with Jun/Fos, with the resulting ternary complexes regulating expression of genes, such as metalloprotease-1 (MMP-1) and MMP-3. 20, 21 The seminal studies of Dhordain et al. provided the initial evidence that ERG is expressed at sites of future synovial joint formation in chick embryo limbs. 22 Following that lead, we previously carried out additional studies in chick embryos. We found that ERG was not only expressed at the onset of joint formation, but also persisted once the articular layer had developed further. Aware of the fact that ets proteins can be alternatively spliced, 23 we carried out additional analyses and cloned a variant missing an 81-bp segment (exon 5) in the central portion of ERG. We named this variant C-1-1 and found that it was preferentially, albeit not exclusively, expressed in most epiphyseal chondrocytes in developing long bones. When we misexpressed C-1-1 within the developing chick limb, we observed that C-1-1 was able to impose a stable, immature, and articular-like phenotype onto the entire limb chondrocyte population, effectively blocking maturation and endochondral ossification. 24, 25 To extend our previous studies, we asked whether mammalian cartilages express ERG variants similar to those in chick. Briefly, 5 and 3 RACE procedures were applied using cDNA templates prepared with RNA from human cartilage and brain. Clones were sequenced and were used to design new primers for the amplification and cloning of entire coding sequences. Clones characterized so far are schematically represented in FIGURE 4 and are named according to Duterque-Coquillaud et al. 23 : (a) a prototypical ERGp38 containing the 81-bp exon and a short N terminus; (b) ERG-1 containing the 81-bp exon and a longer N terminus; (c) ERGp55 containing both the 81-and 72-bp exons and corresponding to chick ERG; and (d) ERGp55 81 that contains the 72-bp exon but lacks the 81-bp exon and corresponds to chick C-1-1. In related experiments, we screened a mouse embryo cDNA library by GeneTrapper (Invitrogen, Carlsbad, CA) and cloned several ERG variants; however, we have not found a mouse C-1-1-like variant so far. 26 Having identified a human C-1-1 homologue, it became important to ask whether this variant has biological properties similar to those of chick C-1-1. Thus, we prepared a construct encoding human ERGp55 81 under the control of mouse Col2a1 promotor/enhancer sequences and used it to produce transgenic mice. The Col2 promotor/enhancer sequences were those that we previously used to misexpress RUNX2 (or a dominant-negative form of it) in transgenic mice. 27 Constructs were microinjected into the pronuclei of fertilized eggs by a centralized facility. Transgenic mice were identified by polymerase chain reaction (PCR) and southern hybridization. The expression of the transgene product was monitored by immunostaining of tissue sections with ERG antibodies that recognize the C-terminal 20 amino acid-long portion of the protein (common to all ERG variants). We obtained 6 mice that overexpressed ERGp55 81 in cartilage out of a total of 45 transgene-positive mice. Since ERGp55 81-overexpressing mice die at birth due to respiratory failure, we carried out most of our analyses on E18.5 embryos.
The skeletal phenotype of the transgenic (TG) embryos was severe. Anatomical analysis showed that TG embryos were much smaller than wild-type (WT) littermates (FIGS. 5A,B) and their trunk and limb skeletal elements were hypomineralized and stained poorly with alizarin red (not shown). Limbs were sectioned longitudinally and serial sections were processed for histology and in situ hybridization. Wild-type E18.5 tibias displayed a typical histology with a prominent epiphyseal cartilaginous cap (where a secondary ossification center will eventually form) and a well-organized growth plate in the metaphysis followed by abundant bone and marrow (FIG. 5C) . Instead, the transgenic tibias were completely disorganized (FIG. 5D) . Typical growth plates were absent and most of the chondrocytes, regardless of location, had a small and fairly uniform diameter; there was bone-like tissue in the diaphysis, but it appeared fibrotic and poor in marrow (FIG. 5D) . Gene expression of aggrecan FIGURE 5. Anatomical, histological, and in situ hybridization analyses of developing skeleton. Day E18.5 wild-type (WT) mouse embryos and transgenic embryos expressing human ERGp55 81 in cartilage (TG) were processed for skeletal anatomical analysis (A and B), histology (C and D), and in situ hybridization analysis of collagen X gene expression (E and F). Note in WT that the skeleton and long bone growth plate have normal appearances (A and C) and normal strong expression of maturation marker collagen X (E). In contrast, the transgenic skeleton is much smaller (B), the growth plate is completely disorganized and composed of uniform chondrocytes displaying an immature small-sized appearance (D), and there is poor expression of collagen X (F).
and other cartilage-characteristic matrix genes was equally strong in wildtype and transgenic cartilages, indicating that transgene expression was not causing de-differentiation or having other unwanted side effects (not shown). However, expression of gene markers of maturation, such as collagen X was markedly reduced in transgenic (FIG. 5F ) versus wild-type cartilage (FIG. 5E) . On the other hand, the epiphyseal articular cartilage marker tenascin-C was widely expressed throughout the transgenic cartilage, but was confined to the epiphyseal cartilaginous ends in wild type as to be expected (not shown).
CONCLUSIONS AND IMPLICATIONS
Synovial joint formation has attracted the interest of developmental biologists for decades, but its mechanisms of regulation have remained poorly understood, a reflection of the sheer complexity and intricacies of the process. The interzone has long been regarded as a critical player in joint formation. Studies by Holder originally revealed that microsurgical removal of incipient interzones in developing limb skeletal elements leads to joint ablation and fusion of contiguous cartilaginous elements. 5 Work by Archer and collaborators showed that interzone cells have special cytological characteristics, particularly gap junctions, which distinguish them from the condensed mesenchyme of neighboring skeletal anlagen. 3 Interest in interzone cells has been reinvigorated by recent studies showing that the cells are characterized by expression of specific genes, including GDF-5, GDF-6, Wnt-14, chordin, and Cux1. [28] [29] [30] [31] [32] These genes are thought to be crucial for joint formation, but their exact functions are not fully clear. The DiI data from chick embryos we present here now indicate that mesenchymal cells present at peri-joint sites migrate into the incipient joint and interzone and become part of the epiphyseal articulating layer of long bone anlagen. However, cells located a few hundred microns away appear to be equally mobile and are found scattered up and down the limb mesenchyme, but do not become part of the developing joint. In addition, our studies with cultured interzone cells provide the most direct evidence to date that interzone cells are indeed chondrogenic and can differentiate into chondrocytes. Together, our data suggest that: the cell origin of the interzone is more complex than previously realized; the interzone is constituted in part or entirely of cells that originate from peri-joint sites; and interzone cells may thus be endowed with special and unique characteristics, including the ability to give rise to articular chondrocytes. The fact that only peri-joint cells immediately adjacent to a nascent joint appear to be able to migrate and take part in interzone formation suggests that those cells and the microenvironment in which they reside may both be special. The microenvironment could represent a niche. Thus, a detailed understanding of those cells and their niche could be of great significance and could be used therapeutically to create new cell-based means for joint and articular cartilage reconstruction and repair.
A critical issue in developmental biology is the identification of genes, and master genes in particular, that are critical for establishing the differentiated phenotype of specific cell types. However, it has long remained unclear what genes regulate the genesis of articular chondrocytes and allow the cells to retain a permanent differentiated phenotype throughout life. As pointed out above, such longevity and phenotypic stability are remarkably different from the characteristics of transient growth plate chondrocytes that instead have a limited life span, undergo major changes in phenotype, and eventually die and are replaced by bone cells. The data presented here provide further support for our earlier studies that the transcription factor ERG is part of the molecular mechanisms by which articular chondrocytes form and function. 24, 25, 33 Both avian and human C-1-1 are able to block the maturation of chondrocytes in vitro and in vivo, and the ERG overexpressing chondrocytes all display an immature articular-like phenotype characterized by a small cell size, expression of aggrecan and other typical cartilage matrix components, and expression of articular cartilage-specific traits, such as tenascin-C. 34 It is possible then that when chondrocytes first emerge in a developing joint (likely as the progeny of interzone cells), local expression of ERG may direct the cells toward a permanent path and immediately set them apart from neighboring transient chondrocytes in the cartilaginous anlagen that instead become organized in growth plates and undergo endochondral ossification. 26, 33 It will be of great interest to establish whether ERG expression is altered in disease states, such as osteoarthritis and whether this may be associated to, or even cause, loss of a permanent phenotype and initiation of a pathological process of maturation and hypertrophy in articular chondrocytes. If so, therapies directed to revamping ERG expression or boosting its function could represent novel means of intervention on joint disease. Ongoing studies should provide answers to these intriguing possibilities.
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